SC

Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China

Retrieved on: 
星期一, 九月 18, 2023
SC, Safety, Policy, Breakthrough therapy, Quality of life, Medicine, ECI, Autoimmunity, HKEX, Chronic inflammatory demyelinating polyneuropathy, Patient, Risk, National Medical Products Administration, Breakthrough, Immunoglobulin G, CDE, International development, Biology, Center for Drug Evaluation and Research, NMPA, Infection, Autoantibody, Pharmaceutical industry, Rare-earth element, CIDP, Neuroscience

SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) granted Breakthrough Therapy Designation for efgartigimod alfa injection (subcutaneous injection) (efgartigimod SC) for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

Key Points: 
  • SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) granted Breakthrough Therapy Designation for efgartigimod alfa injection (subcutaneous injection) (efgartigimod SC) for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
  • The Breakthrough Therapy Designation for efgartigimod SC was supported by data from both global and Chinese patients enrolled in the ADHERE study.
  • “We have seen how efgartigimod SC can meaningfully improve and stabilize disease symptoms in these patients.
  • Existing treatment options are quite limited, and problematic given the general reliance on long-term steroid or chronic immunoglobulin therapy.

INE Recognized as Top Training Provider by G2, Training Industry, Global Infosec, and SC Media

Retrieved on: 
星期一, 九月 18, 2023
Online, Learning, Partnership, ELearnSecurity, SC, INE, National Initiative for Cybersecurity Education, Certification, Organization, Experience, Computer security, Online shopping, G2

CARY, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) -- INE , the leading provider of cybersecurity and networking technical training and certifications, is proud to be the named a top 2023 training provider by industry-recognized organizations including G2, Training Industry, Global Infosec, and SC Media.

Key Points: 
  • CARY, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) -- INE , the leading provider of cybersecurity and networking technical training and certifications, is proud to be the named a top 2023 training provider by industry-recognized organizations including G2, Training Industry, Global Infosec, and SC Media.
  • INE was also selected as a 2023 SC Media Excellence Award Finalist for Best Certification Program and Best IT Security-Related Training Program.
  • Earlier this month, INE announced the creation of INE Security , officially integrating eLearnSecurity into the INE parent brand.
  • INE also just announced a new partnership with Accredible , empowering learners and enterprise clients to leverage digital badging as part of their training journey.

SC Ventures Launches audax Financial Technology to Help Financial Institutions Accelerate Digital Banking Capabilities

Retrieved on: 
星期四, 九月 21, 2023
Professional Services, Online Retail, Cosmetics, Retail, Finance, Fintech, Banking, Partnership, Arm, SC, Standard Chartered, Audax, Intelligence, Digital banking, Acquisition, As a service, Growth, Ecosystem, Bukalapak, Cryptocurrency, Online shopping, Bank

SC Ventures , Standard Chartered’s innovation, fintech investment and ventures arm, launches audax Financial Technology (“audax”), a digital banking technology solutions provider.

Key Points: 
  • SC Ventures , Standard Chartered’s innovation, fintech investment and ventures arm, launches audax Financial Technology (“audax”), a digital banking technology solutions provider.
  • audax provides an end-to-end digital banking platform with modularised capabilities that are designed to efficiently handle millions of customer data concurrently.
  • “audax’s digital banking solutions will help financial institutions unlock more opportunities,” said Alex Manson, who leads SC Ventures.
  • SC Ventures was established in 2018 as a new business unit to lead digital innovation and to invest in Financial Technology companies.

Stephen Marley’s Old Soul Out Now on All Streaming Platforms, Marking the 8x GRAMMY® Winner’s First Album in 7+ Years

Retrieved on: 
星期五, 九月 15, 2023
Music, Online, Mobile Entertainment, Events, Concerts, Entertainment, Lee, VA, Bass, PA, Vogue Theatre, Wolf Bros, Center Stage, San Francisco International Arts Festival, SC, Foolish Things, OR, Sun, Sheriff, Death, MD, Metaphor, NH, Multimedia, Grateful Dead, COVID, In Love, Dead & Company, Roxy, Reward, Walking Dead, Cast the First Stone (Ensign album), Old soul, MA, LA, Slightly Stoopid, Breeze, Nightclub, Fireworks, Tourism, Amusement park, Love, Silver, Bob Marley

Featuring a stellar line-up of special guests, including Bob Weir, Eric Clapton, Jack Johnson, Ziggy Marley, Damian “Jr.

Key Points: 
  • Featuring a stellar line-up of special guests, including Bob Weir, Eric Clapton, Jack Johnson, Ziggy Marley, Damian “Jr.
  • Old Soul will be available on CD, a 2LP standard black vinyl, and as a limited-edition double LP vinyl in translucent yellow and green on December 1st.
  • (Graphic: UMe)
    Bob Weir of the Grateful Dead and singer/songwriter Jack Johnson join Marley on “ Winding Roads ,” the album’s latest single.
  • Who dig it, dig it.”
    In celebration of the new album, Stephen Marley has embarked on his ambitious Old Soul Tour Unplugged 2023.

Endpoint Security Market to grow by USD 12.76 billion from 2022 to 2027, Market driven by the emergence of enterprise mobility and BYOD policy among enterprises - Technavio

Retrieved on: 
星期五, 九月 15, 2023
Cloud, Unified endpoint management, Endpoint, BlackBerry Limited, USB, UEM, Computer, Fortinet, Internet, Analysis, McAfee, Malwarebytes, Inc. v. Enigma Software Group USA, LLC, Software, ISO, Policy, Broadcom Inc., Certification, Organization, Microsoft, ISO 9001:2015, Growth, Knowledge, Health, BlackBerry, MDM, VMware, SME, SC, Key (company), Cisco, Large, BFSI, Deployment, Kaspersky Lab, BYOD, Online shopping, Retail, Sophos, Symantec, Geography

The potential growth difference for the endpoint security market between 2022 and 2027 is USD 12.76 billion.

Key Points: 
  • The potential growth difference for the endpoint security market between 2022 and 2027 is USD 12.76 billion.
  • The emergence of enterprise mobility and BYOD policy among enterprises is notably driving market growth.
  • Including BYOD, the company has chosen Symantec Endpoint Protection Mobile to enforce mobile security policies across all devices in its organizations.
  • Thus, the adoption of endpoint security software by businesses can drive the growth of the endpoint security market during the forecast period.

argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis

Retrieved on: 
星期五, 九月 15, 2023
1991 World Sportscar Championship, IV, Marketing, SC, GMG, European Medicines Agency, Committee for Medicinal Products for Human Use, Quality of life, Committee, EMA, Euronext, Patient, Physician, ADAPT, Autoimmune disease, Ghent University, Immunoglobulin G, SE, Acetylcholine receptor, Ghent University Hospital, EC, CHMP, Pharmaceutical industry, Vaccine

SC efgartigimod is formulated with Halozyme’s ENHANZE® drug delivery technology to facilitate subcutaneous delivery of biologics.

Key Points: 
  • SC efgartigimod is formulated with Halozyme’s ENHANZE® drug delivery technology to facilitate subcutaneous delivery of biologics.
  • “Generalized myasthenia gravis is a complex and devastating disease that is debilitating for people who live with it, making routine movements exhausting and challenging to perform,” said Prof. dr. Jan De Bleecker, Ghent University Hospital and Ghent University.
  • The positive CHMP opinion is a scientific recommendation for marketing authorization, serving as a basis for the EC’s final decision on argenx’s application for SC efgartigimod.
  • The decision will apply to all 27 European Union Member States, and also to Iceland, Norway and Liechtenstein.

LiveStock Impact, Inc., a Wholly Owned Subsidiary of BioAdaptives, Inc., Announces the Appointments of two Experts to Board of Directors

Retrieved on: 
星期四, 九月 14, 2023
NCHA, Horse, National Cutting Horse Association, SC, Research, Retirement, Animal, World championship, Laboratory, Knowledge, Diagnosis, OK, Health, Veterinary medicine

LAS VEGAS, NV, Sept. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – LiveStock Impact, Inc., a wholly owned subsidiary of  BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the appointment of two new members to its Board of Directors, Bruce Colclasure and Charles Timmerman, D.V.M.  Both members are well recognized experts in their respective fields who are expected to bolster the effectiveness of the Board in guiding the creation of superior animal health products and sharpening the penetration of global markets.

Key Points: 
  • Bruce Colclasure, Bristow, OK, is the owner of the Flying C Bar Ranch and Patriot Sales and Productions, LLC.
  • Bruce Colclasure is proud of these lifetime credentials but what he prides himself of the most is the accomplishments in the different equine disciplines.
  • Bruce Colclasure states, “I am excited to serve on the Board of LiveStock Impact.
  • Inc. at this moment when the demand for Equine All in One and the other Livestock Impact products is sharply increased.

Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease

Retrieved on: 
星期三, 九月 13, 2023
Nursing, FDA, Genetics, Clinical Trials, Practice Management, Biotechnology, Health, Pharmaceutical, Oncology, CD, Week, SC, TAK, Clinical trial, Head, Ulcerative colitis, Inflammatory bowel disease, UC, Patient, Gastroenterology, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BLA, Food, Safety, Pharmaceutical industry, Takeda

Takeda ( TSE:4502/NYSE:TAK ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the investigational subcutaneous (SC) administration of ENTYVIO® (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn’s disease (CD) after induction therapy with ENTYVIO intravenous (IV).

Key Points: 
  • Takeda ( TSE:4502/NYSE:TAK ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the investigational subcutaneous (SC) administration of ENTYVIO® (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn’s disease (CD) after induction therapy with ENTYVIO intravenous (IV).
  • An application for the SC administration of ENTYVIO for the treatment of adults with moderately to severely active ulcerative colitis (UC) is also under review by the FDA .
  • “Every patient journey is different, and every patient has a unique set of medical needs and personal preferences.
  • Patients were randomized 2:1 to SC administration of ENTYVIO 108 mg or placebo every 2 weeks.

Cognito Forms: Four Straight Years as a Top Workplace in South Carolina

Retrieved on: 
星期四, 九月 7, 2023
Workplace, Pleasure, Creativity, Human, Career, SC, Management, Cognito

Cognito Forms was honored after a rigorous two-phase survey process conducted by SC BIZ with 111 companies.

Key Points: 
  • Cognito Forms was honored after a rigorous two-phase survey process conducted by SC BIZ with 111 companies.
  • Cognito Forms earned approval from 96% of their employees, placing them in the top three for small businesses.
  • Cognito Forms is committed to enhancing its workplace, innovating in the industry, and building stronger community connections.
  • If you share our values and vision for innovation, we invite you to explore career opportunities with us at Careers - Cognito Forms .

TEGNA Appoints Carrie Hofmann President and General Manager of WLTX in Columbia, South Carolina

Retrieved on: 
星期三, 九月 6, 2023
Entertainment, Communications, General Entertainment, TV and Radio, Other Communications, Media, WTMJ, SC, WCNC, TGNA, TEGNA, Multimedia, CBS, NBC, KSAZ, News station, Ailsa Chang, IA Financial Group, WLTX-TV, Arizona State University, WLTX, ABC, KMGH, News, NYSE, KSHB, Management

TEGNA Inc. (NYSE: TGNA) today announced that Carrie Hofmann has been named president and general manager of WLTX, TEGNA’s CBS affiliate in Columbia, SC, effective October 2.

Key Points: 
  • TEGNA Inc. (NYSE: TGNA) today announced that Carrie Hofmann has been named president and general manager of WLTX, TEGNA’s CBS affiliate in Columbia, SC, effective October 2.
  • Hofmann will be responsible for overseeing the station’s operations across all platforms, as well as community outreach efforts and driving results for advertisers.
  • View the full release here: https://www.businesswire.com/news/home/20230906364867/en/
    Carrie Hofmann has been named president and general manager at TEGNA's WLTX-TV.
  • Hofmann is a graduate of Arizona State University with a Bachelor of Arts degree in Broadcast Journalism.